Related references
Note: Only part of the references are listed.Rucaparib cocrystal: Improved solubility and bioavailability over camsylate
Mengyuan Xia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(iv) prodrugs
Shu Chen et al.
DALTON TRANSACTIONS (2022)
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
Geetha Bolla et al.
CHEMICAL REVIEWS (2022)
The first marine dual-drug cocrystal of cytarabine with 5-fluorouracil having synergistic antitumor effects shows superior biopharmaceutical peculiarities by oral administration
Yue-Ming Yu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration
Alessandra Barbanente et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Synthesis and characterization of thiocarbonato-linked platinum(IV) complexes
Marie-Christin Barth et al.
DALTON TRANSACTIONS (2022)
Slow-Release Drug-Drug Cocrystals of Oxaliplatin with Flavonoids: Delaying Hydrolysis and Reducing Toxicity
He-Mei Yin et al.
CRYSTAL GROWTH & DESIGN (2021)
Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility
Weizhong Gong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Recent advances in the synthesis, stability, and activation of platinum (IV) anticancer prodrugs
Zoufeng Xu et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Effect of mechanochemical grinding conditions on the formation of pharmaceutical cocrystals and co-amorphous solid forms of ketoconazole-Dicarboxylic acid
Md Sadeque Hossain Mithu et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
SMINBR: An Integrated Network and Chemoinformatics Tool Specialized for Prediction of Two-Component Crystal Formation
Lulu Zheng et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Drug-Drug Cocrystals Provide Significant Improvements of Drug Properties in Treatment with Progesterone
Chunyang Guo et al.
CRYSTAL GROWTH & DESIGN (2020)
A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism
Zhiqin Deng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues
Shu Chen et al.
INORGANIC CHEMISTRY (2020)
Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer
S. C. Lindgaard et al.
BREAST (2019)
Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect
Takehiro Kawashiri et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Enhancing the Pharmaceutical Properties of Pirfenidone by Mechanochemical Cocrystallization
Nimmy Kumari et al.
CRYSTAL GROWTH & DESIGN (2019)
Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering
Jin-Yao Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
The reduction of cis-platinum(iv) complexes by ascorbate and in whole human blood models using 1H NMR and XANES spectroscopy
Catherine K. J. Chen et al.
METALLOMICS (2019)
Solid-State Characterization and Relative Formation Enthalpies To Evaluate Stability of Cocrystals of an Antidiabetic Drug
Naga Kiran Duggirala et al.
MOLECULAR PHARMACEUTICS (2018)
Electrodrugs: an electrochemical prodrug activation strategy
Daniel J. Norman et al.
CHEMICAL COMMUNICATIONS (2018)
Platinum(IV) Prodrugs - A Step Closer to Ehrlich's Vision?
Reece G. Kenny et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Preparation of a 1:1 cocrystal of genistein with 4,4′-bipyridine
Yu-Nan Zhang et al.
JOURNAL OF CRYSTAL GROWTH (2017)
Cocrystals of kaempferol, quercetin and myricetin with 4,4′-bipyridine: Crystal structures, analyses of intermolecular interactions and antibacterial properties
Yu -Nan Zhang et al.
JOURNAL OF MOLECULAR STRUCTURE (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Improving the Solubility and Bioavailability of Apixaban via Apixaban-Oxalic Acid Cocrystal
Yong Chen et al.
CRYSTAL GROWTH & DESIGN (2016)
Platinum(IV) anticancer prodrugs - hypotheses and facts
Dan Gibson
DALTON TRANSACTIONS (2016)
Oxaliplatin triggers necrosis as well as apoptosis in gastric cancer SGC-7901 cells
Ping Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions
Palash Sanphui et al.
MOLECULAR PHARMACEUTICS (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Cocrystals of the Tuberculosis Drug Isoniazid: Polymorphism, Isostructurality, and Stability
Battini Swapna et al.
CRYSTAL GROWTH & DESIGN (2014)
Pros and cons of bifunctional platinum(IV) antitumor prodrugs: two are (not always) better than one
Elisabetta Gabano et al.
DALTON TRANSACTIONS (2014)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
Jenny Z. Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation
Chee Fei Chin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity
V. A. Carozzi et al.
CURRENT CANCER DRUG TARGETS (2010)
Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution
David R. Weyna et al.
CRYSTAL GROWTH & DESIGN (2009)
The mechanism of action of platinum anticancer agents-what do we really know about it?
Dan Gibson
DALTON TRANSACTIONS (2009)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Organic cation transporters are determinants of oxaliplatin cytotoxicity
Shuzhong Zhang et al.
CANCER RESEARCH (2006)
Satraplatin: an orally available platinum analog for the treatment of cancer
Hak Choy
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs
V Brabec et al.
DRUG RESISTANCE UPDATES (2005)
Update of the preclinical situation of anticancer platinum complexes: Novel design strategies and innovative analytical approaches
M Galanski et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)